34
Participants
Start Date
October 18, 2017
Primary Completion Date
October 28, 2020
Study Completion Date
October 28, 2020
ARGX-113
human IgG1-derived Fc fragment that binds to human neonatal Fc receptor (FcRn)
University of Lübeck and UKSH, Department of Dermatology and Lübeck Institute of Experimental Dermatology, Lübeck
Clinic of Dermatology and Allergology - Philipps University Marburg, Marburg
University of Debrecen Medical Center Department of Dermatology, Debrecen
University of Pécs Clinical Center , Department of Dermatology, Venerology and Oncodermatology, Pécs
University of Szeged Faculty of Medicine Albert Szent-Györgyi Medical Center Department of Dermatology and Allergology, Szeged
HaEmek Medical center, Dermatology Department, Afula
Department of Dermatology, The Chaim Sheba Medical Center, Tel Aviv
Department of dermatology, The Tel Aviv Sourasky Medical Center, Tel Aviv
"Dermopathic Institute of the Immaculate - Foundation Luigi Maria Monti", Rome
Foundation Policlinico A. Gemelli - Dermatology Department, Rome
National Medical University named after O.O.Bohomolets, Department of Dermatology and Venereology based on Oleksandrivska Clinical Hospital of Kyiv City, Department of Dermatology, Kyiv
"Municipal Institution Zaporizhzhya Regional Dermatology and Venereology Clinical Dispensary of Zaporizhzhya Regional Council", Zaporizhzhya
Lead Sponsor
argenx
INDUSTRY